Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Mediar is a pre-clinical stage biotechnology company developing therapeutics for the treatment of fibrosis.
Nuage Therapeutics engages in developing drugs which target proteins in disordered regions for challenging indications faced by patients.
Amolyt Pharma specializes in peptides for the treatment of rare endocrine and metabolic disorders.
Mablink Bioscience is a biotechnology company.
CinCor is a clinical-stage biopharmaceutical company that develops treatments for cardiovascular diseases.
Inspirna is a biotechnology company developing drugs for the treatment of cancer.
Biosyntia is a biotech startup within synthetic biology and metabolic engineering.
Redx Pharma is a drug discovery and development company.
LimFlow SA is a venture-backed medical device company.
HotSpot Therapeutics is a developer of a therapy platform designed to discover medicines and provide proper treatment.
Synthace is a SaaS Life Sciences R&D Digital Experiment Platform.
Home Biosciences is a European venture builder dedicated to biotech.
Nitrase Therapeutics is developing drugs against newly discovered nitration enzyme(s).
Sphere Bio specializes in tools for single cell analysis and isolation, facilitating discovery in the biotech field.
iOmx Therapeutics focuses on the development of cancer immunotherapy treatments.
Protera is a biotechnology company that produce protein-based food ingredients.
A French biotechnology company that uses precision fermentation to produce real dairy products, accessible to everyone.
BrightHeart is a medical technology startup that is developing artificial intelligence software.
Muna Therapeutics discovers and develops therapies that slow or stop neurodegenerative diseases such as alzheimer’s and parkinson's.
ProQR Therapeutics is a biotech company focused on developments of drugs to treat genetic disorders.
DISCO Pharmaceuticals is a firm that specializes in large-scale surfaceome unlocking of cancer cells.
Excelsior Sciences applies AI and automated chemistry to simplify small-molecule discovery and accelerate overall drug development.
myTomorrows is a global platform that connects patients with unmet medical needs to treatments in development around the world.
Real Leather, Reinvented
Sofinnova Partners has invested in 150 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Sofinnova Partners's top investment sectors include Biotechnology, Pharmaceutical, Health Care, Medical, Therapeutics. The firm invests across 17 different industry categories.
Among tracked funding rounds, CinCor Pharma received $225.0M in a Post-IPO Equity round. Sofinnova Partners's total known invested capital is $7.1B.
Sofinnova Partners's average investment size is $47.4M across its portfolio of 150 companies.
Recent Sofinnova Partners portfolio additions include Mediar Therapeutics, Nuage Therapeutics, Amolyt Pharma, Mablink Bioscience, CinCor Pharma. These companies were founded in 2020 or later.